Showing 1 - 10 of 30
We study the impact of product margins on pharmacies' incentive to promote generics instead of brand-names. First, we construct a theoretical model where pharmacies can persuade patients with a brand-name prescription to purchase a generic version instead. We show that pharmacies' substitution...
Persistent link: https://www.econbiz.de/10009691207
Persistent link: https://www.econbiz.de/10009762378
We study the impact of regulation on competition between brand-names and generics and pharmaceutical expenditures using a unique policy experiment in Norway, where reference pricing (RP) replaced price cap regulation in 2003 for a sub-sample of off-patent products. First, we construct a vertical...
Persistent link: https://www.econbiz.de/10008749029
Persistent link: https://www.econbiz.de/10009270541
Persistent link: https://www.econbiz.de/10013350399
Persistent link: https://www.econbiz.de/10014297008
Persistent link: https://www.econbiz.de/10014426057
Persistent link: https://www.econbiz.de/10008655517
Persistent link: https://www.econbiz.de/10010379568
Persistent link: https://www.econbiz.de/10003900155